
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.460 | 4.460 | 0.000 |
Shares | 95.540 | 95.540 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.762 | 18.180 |
Price to Book | 6.039 | 3.341 |
Price to Sales | 3.040 | 2.195 |
Price to Cash Flow | 16.031 | 13.545 |
Dividend Yield | 2.640 | 2.931 |
5 Years Earnings Growth | 6.659 | 8.942 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 36.250 | 30.757 |
Industrials | 20.520 | 15.837 |
Consumer Defensive | 14.580 | 12.701 |
Financial Services | 12.120 | 21.739 |
Basic Materials | 10.210 | 8.157 |
Consumer Cyclical | 4.730 | 5.286 |
Technology | 1.590 | 3.428 |
Number of long holdings: 23
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 13.93 | 71.14 | +0.20% | |
Roche Holding Participation | CH0012032048 | 11.42 | 253.50 | -0.59% | |
Novartis | CH0012005267 | 10.31 | 98.40 | +0.41% | |
Zurich Insurance Group | CH0011075394 | 7.81 | 562.00 | +1.55% | |
Lonza Group | CH0013841017 | 6.38 | 522.80 | +0.93% | |
ABB | CH0012221716 | 6.36 | 56.72 | +0.89% | |
Givaudan | CH0010645932 | 5.71 | 3,195.00 | +0.28% | |
Belimo Holding | CH1101098163 | 4.18 | 813.0 | -0.18% | |
Sika | CH0418792922 | 4.05 | 174.00 | +0.55% | |
Partners Group | CH0024608827 | 3.76 | 1,030.00 | -0.10% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BCV PENSION 25 AP | 930.07M | 1.38 | 3.84 | 2.09 | ||
BCV PENSION 40 AP | 674.82M | 2.41 | 4.92 | 3.54 | ||
Synchrony All Caps CH I | 575.13M | 3.86 | 2.80 | 7.28 | ||
Synchrony Small Mid Caps CH I | 178.7M | 5.92 | 2.26 | 7.59 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review